Clinical Trial Update: Study Evaluating Efficacy And Tolerability Of Veliparib in Combination With Temozolomide (TMZ) or In Combination With Carboplatin and Paclitaxel Versus Placebo in Participants With Breast Cancer Gene (BRCA)1 and BRCA2 Mutation and Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating veliparib with temozolomide or with carboplatin/paclitaxel versus placebo in BRCA1/2-mutated metastatic breast cancer; trial completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• Temozolomide (Temozolomide)
• Veliparib (veliparib)

Snippet

Sponsor: AbbVie | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2021-10-25